Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 4, 2010, Pages 1547-1552

  Stagg, John ^a   Divisekera, Upulie ^a   McLaughlin, Nicole ^a   Sharkey, Janelle ^a   Pommey, Sandra ^b,c   Denoyer, Delphine ^a   Dwyer, Karen M ^b,c   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adenosine; Cancer; Chemotaxis; Immunosuppression; Regulatory

Indexed keywords

5' NUCLEOTIDASE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CHEMOTAXIS; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG MECHANISM; FEMALE; IMMUNOCOMPETENCE; IMMUNOTHERAPY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

5'-NUCLEOTIDASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

MUS;

EID: 75949112218     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0908801107     Document Type: Article

References (47)

1. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: Guardians of the body. Annu Rev Immunol 27:229-265.
2. Mizumoto N, et al. (2002) CD39 is the dominant Langerhans cell-associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness. Nat Med 8: 358-365.
3. Frick JS, et al. (2009) Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol 182:4957-4964.
4. Novitskiy SV, et al. (2008) Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112:1822-1831.
5. Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A (2008) Hypoxia-adenosinergic immunosuppression: Tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 14:5947-5952.
6. Haskó G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759-770.
7. Linden J (2001) Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41:775-787.
8. Ohta A, et al. (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 103:13132-13137.
9. Pellegatti P, et al. (2008) Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase. PLoS One 3:e2599.
10. Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J (2008) Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int J Oncol 32:527-535.
11. Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5?-nucleotidase (CD73). Purinergic Signal 2:351-360.
12. Resta R, Yamashita Y, Thompson LF (1998) Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 161:95-109.
13. Synnestvedt K, et al. (2002) Ecto-5′-nucleotidase (CD73) regulation by hypoxiainducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002.
14. Thompson LF, et al. (2004) Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200:1395-1405.
15. Niemelä J, et al. (2008) IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur J Immunol 38:2718-2726.
16. Lennon PF, Taylor CT, Stahl GL, Colgan SP (1998) Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 188: 1433-1443.
17. Takedachi M, et al. (2008) CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol 180:6288-6296.
18. Madara JL, et al. (1993) 5′-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 91:2320-2325.
19. Stella J, et al. (2009) Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol, 10.1016/j.urolonc.2009.01.035.
20. Mikhailov A, et al. (2008) CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis. J Immunol 181:464-475.
21. Bavaresco L, et al. (2008) The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation. Mol Cell Biochem 319:61-68.
22. Ludwig HC, Rausch S, Schallock K, Markakis E (1999) Expression of CD 73 (ecto-5?-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res 19:1747-1752.
23. Sadej R, Spychala J, Skladanowski AC (2006) Ecto-5′-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells. Nucleosides Nucleotides Nucleic Acids 25:1119-1123.
24. Cho SY, et al. (2006) In vitro evaluation of adenosine 5′-monophosphate as an imaging agent of tumor metabolism. J Nucl Med 47:837-845.
25. Kondo T, Nakazawa T, Murata SI, Katoh R (2006) Expression of CD73 and its ecto-5′-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 48: 612-614.
26. Fukuda K, et al. (2004) Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 91:1543-1550.
27. Hastie C, et al. (2005) Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells. Oncogene 24:5905-5913.
28. Spychala J, et al. (2004) Role of estrogen receptor in the regulation of ecto-5?-nucleotidase and adenosine in breast cancer. Clin Cancer Res 10:708-717.
29. Wang L, et al. (2008) Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol 134:365-372.
30. Lee H, Lin EC, Liu L, Smith JW (2003) Gene expression profiling of tumor xenografts: In vivo analysis of organ-specific metastasis. Int J Cancer 107:528-534.
31. Leth-Larsen R, et al. (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics 8:1436-1449.
32. Eckhardt BL, et al. (2005) Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 3:1-13.
33. Takeda H, et al. (2006) Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 12:395-397.
34. Ujházy P, et al. (1996) Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. Int J Cancer 68:493-500.
35. Zhi X, et al. (2007) RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis 24:439-448.
36. Chen Y, et al. (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314:1792-1795.
37. Richard CL, Tan EY, Blay J (2006) Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha. Int J Cancer 119:2044-2053.
38. Tan EY, Mujoomdar M, Blay J (2004) Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: Implications for cancer cell behavior. Am J Pathol 165:319-330.
39. Goldfinger LE, Han J, Kiosses WB, Howe AK, Ginsberg MH (2003) Spatial restriction of alpha4 integrin phosphorylation regulates lamellipodial stability and alpha4beta1-dependent cell migration. J Cell Biol 162:731-741.
40. Lim CJ, et al. (2008) Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol Biol Cell 19:4930-4941.
41. Airas L, Niemelä J, Jalkanen S (2000) CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. J Immunol 165:5411-5417.
42. Mills JH, et al. (2008) CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105:9325-9330.
43. Möller A, et al. (2009) Inhibition of Siah ubiquitin ligase function. Oncogene 28: 289-296.
44. Stagg J, et al. (2008) Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response. Proc Natl Acad Sci USA 105: 16254-16259.
45. Eckle T, et al. (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111:2024-2035.
46. Koeppen M, Eckle T, Eltzschig HK (2009) Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS One 4:e6784.
47. Deaglio S, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257-1265.